Person who experienced the adverse event (patient)
| Event ID | CASE | I F COD | FOLL SEQ | IMAGE | EVENT DT | MFR DT | FDA DT | REPT COD | MFR NUM | MFR SNDR | AGE | AGE COD | GNDR COD | E SUB | WT | WT COD | REPT DT | OCCP COD | DEATH DT | TO MFR | CONFID | REPORTER COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 6758790 | 7415156 | I | 6758790-9 | 20090907 | 20100525 | 20100603 | EXP | TPG2009A00990 | TAKEDA PHARMACEUTICALS NORTH AMERICA. | 72 | YR | M | N | 20100602 | GERMANY |
Drug(s) used by person
| Event ID | DRUG SEQ | ROLE COD | DRUGNAME | VAL VBM | ROUTE | DOSE VBM | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 6758790 | 1013820031 | PS | CANDESARTAN CILEXETIL | 1 | ORAL | 16 MG PER ORAL | Y | D | 21073 | ||
| 6758790 | 1013837982 | SS | ACTOS | 1 | ORAL | 15 MG PER ORAL, 30 MG PER ORAL | |||||
| 6758790 | 1013837983 | C | AGGRENOX | 1 | |||||||
| 6758790 | 1013837984 | C | SIMVASTATIN | 1 | |||||||
| 6758790 | 1013837985 | C | GLIMEPIRIDE | 1 | |||||||
| 6758790 | 1013837986 | C | CARVEDILOL | 1 | |||||||
| 6758790 | 1013837987 | C | TORSEMIDE | 1 | |||||||
| 6758790 | 1013837988 | C | SODIUM POLYSTYRENE SULFONATE | 1 |
Indications of drugs used
| Event ID | DRUG SEQ | INDI PT |
|---|---|---|
| 6758790 | 1013820031 | HYPERTENSION |
| 6758790 | 1013837982 | DIABETES MELLITUS |
Outcome of event
| Event ID | OUTC COD |
|---|---|
| 6758790 | OT |
Reactions reported
| Event ID | PT |
|---|---|
| 6758790 | HYPERKALAEMIA |
Reporting Sources (this data is often not reported and may therefore be missing here)
| Event ID | RPSR COD |
|---|---|
| 6758790 | FGN |
| 6758790 | HP |
Therapies reported
| Event ID | DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|
| 6758790 | 1013820031 | 20090928 | 20100121 | 115 | DAY |
| 6758790 | 1013837982 | 20081101 | 20090901 | 10 | MON |
| 6758790 | 1013837982 | 20090928 | 20091214 | 77 | DAY |
| 6758790 | 1013837982 | 20091201 |